A greater percentage of PLN cases had an elevated MPO-ANCA level (≥6 U/mL) compared to both matched healthy and SLE without LN disease controls at any time prior to diagnosis (57% versus 0%, p < 0.001; 57% versus 5%, p < 0.001, resp). The gene discussed is MPO; the disease is systemic lupus erythematosus.